Thomas J. Herzfeld Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-30
Closed -$2K 332
2022
Q2
$2K Hold
30
﹤0.01% 300
2022
Q1
$2K Hold
30
﹤0.01% 312
2021
Q4
$3K Hold
30
﹤0.01% 331
2021
Q3
$3K Hold
30
﹤0.01% 315
2021
Q2
$3K Buy
30
+8
+36% +$800 ﹤0.01% 326
2021
Q1
$3K Buy
22
+1
+5% +$136 ﹤0.01% 312
2020
Q4
$3K Buy
21
+6
+40% +$857 ﹤0.01% 273
2020
Q3
$2K Buy
+15
New +$2K ﹤0.01% 244